Approval · Notice of Compliance 6905 · 1998
RIPERCOL INJECTABLE: Notice of Compliance 6905
Issued January 19, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6905
- Date
- January 19, 1998
- Company
- Ayerst Veterinary LaboratoriesGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anthelmintic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RIPERCOL INJECTABLE | 02205947 | Cancelled Post Market |
Medicinal ingredients
- LEVAMISOLE HCL 136.5 MG per ML